EP-1240: Normal tissue exposure in SBRT: Retrospective QA on a prospective cohort - what have we learned?
نویسندگان
چکیده
منابع مشابه
What Have We Learned?
FIVE YEARS AFTER THE INSTITUTE of Medicine (IOM) reported that as many as 98 000 people die annually as the result of medical errors and called for a national effort to make health care safe, it is time to assess our progress. Is health care safer now? And, if not, why not? The IOM’s report, To Err Is Human: Building a Safer Health System, galvanized a dramatically expanded level of conversatio...
متن کاملGOAL: What Have We Learned?
A recent study entitled “Can Guideline-Defined Asthma Control Be Achieved?”1 stands out as one of the most noteworthy clinical studies of the past year because of the important concepts it confirms and because of the many significant questions it raises. Published online in July 2004 and in print in October of the same year, it is referred to by most as the GOAL trial (from the now familiar acr...
متن کاملPathophysiology of Ischemia/Reperfusion-induced Myocardial Injury: What We Have Learned From Preconditioning and Postconditioning?
Organ damage after reperfusion of previously viable ischemic tissues is defined as ischemia/reperfusion injury. The pathophysiology of ischemia/reperfusion injury involves cellular effect of ischemia, reactive oxygen species and inflammatory cascade. Protection against ischemia/reperfusion injury may be achieved by preconditioning or postconditioning. In this review, we discuss basic mechan...
متن کاملHuman Brown Adipose Tissue: What We Have Learned So Far.
Brown adipose tissue (BAT) is a unique tissue that is able to convert chemical energy directly into heat when activated by the sympathetic nervous system. While initially believed to be of relevance only in human newborns and infants, research during recent years provided unequivocal evidence of active BAT in human adults. Moreover, it has become clear that BAT plays an important role in insuli...
متن کاملError in medicine: what have we learned?
O the past decade, it has become increasingly apparent that error in medicine is neither rare nor intractable. Traditionally, medicine has downplayed error as a negligible factor in complications from medieal intervention. But, as data on the magnitude of error aceumulate—-and as the public learns more about them—medical leaders are taking the issue seriously. In particular, the recent publicat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2016
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(16)32490-2